Recombinant human growth hormone in pediatric patients using the FAERS database: Safety profile and update for the period 2004 - 2024

database[Title] 2026-07-09

Summary:

CONCLUSION: A comprehensive safety profile was established for rhGH when used in pediatric populations and comprising several newly identified potential AE signals. The findings underscore the importance of surveillance to mitigate risks and ensure the safe clinical use of rhGH.

Link:

https://pubmed.ncbi.nlm.nih.gov/42390073/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20260709035624&v=2.20.0

From feeds:

📚BioDBS Bibliography » database[Title]

Authors:

Lidan Tu, Huafeng Jiang, Jianming Liu, Yimin Lin, Shuping Wang, Ying Tu, Qingxia Hong

Date tagged:

07/09/2026, 03:56

Date published:

07/02/2026, 06:00